
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT Inc. is positioned for robust future growth, underpinned by potential acquisitions expected to increase by $600 million in 2026, alongside strong performance from its Trilogy segment, which is benefiting from favorable industry trends and improved occupancy. With projections indicating a two-year compound annual growth rate (CAGR) of 11.8% for its seniors housing and skilled nursing facilities and 15.5% for its SHOP segment, the company is poised for significant organic growth driven by an enhanced skill mix and improved Medicare reimbursement rates. Furthermore, the recent improvement in AHR's cost of capital allows management to pursue capital deployment opportunities more aggressively, suggesting that external growth may exceed earlier expectations.
Bears say
American Healthcare REIT Inc. faces potential earnings challenges due to economic headwinds and regulatory changes that could adversely affect tenant performance and impede the company’s ability to meet earnings expectations. Significant risks, including tenant defaults and a downturn in the healthcare industry, could negatively impact the trust's revenues, especially given that a substantial portion of its net operating income derives from skilled nursing facilities. Additionally, pressures from rising construction costs, a competitive market for transactions, and volatility in capital markets could further strain profitability and hinder organic growth aspirations.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares